PRTK Stock Summary

• Paratek Pharmaceuticals Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than only 4.64% of US listed stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 10.85 for Paratek Pharmaceuticals Inc; that's greater than it is for 94.55% of US stocks.
• Revenue growth over the past 12 months for Paratek Pharmaceuticals Inc comes in at 303.37%, a number that bests 98% of the US stocks we're tracking.
• Stocks with similar financial metrics, market capitalization, and price volatility to Paratek Pharmaceuticals Inc are YY, INSM, RDUS, RNWK, and KALA.
• Visit PRTK's SEC page to see the company's official filings. To visit the company's web site, go to paratekpharma.com.